← Back to Search

Behavioural Intervention

Therapy arm for Snoring

N/A
Waitlist Available
Research Sponsored by Signifier Medical Technologies
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change between pre-therapy (day 7) and post therapy (day 49)
Awards & highlights

Summary

This trial will help to improve our understanding of how the eXciteOSA device affects snoring and sleep apnoea and will provide valuable information on whether this new device is an effective treatment for these conditions.

Eligible Conditions
  • Snoring
  • Obstructive Sleep Apnea

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change between pre-therapy (day 7) and post therapy (day 49)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change between pre-therapy (day 7) and post therapy (day 49) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Snoring
Change in sleep disordered breathing indices - Apnea Hypopnea Index (AHI)
Change in sleep disordered breathing indices - Oxygen Desaturation Index (ODI)
Secondary study objectives
Comparison of quality of life questionnaires at start and end of therapy - EQ-5D-5L
Comparison of sleep quality questionnaires at start and end of therapy - Epsworth Sleepiness Score (ESS)
Comparison of sleep quality questionnaires at start and end of therapy - Pittsburgh Sleep Quality Index (PSQI)
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Therapy armExperimental Treatment1 Intervention
Six week use of eXciteOSA device. Once daily for 20 minutes.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
eXciteOSA
2022
N/A
~110

Find a Location

Who is running the clinical trial?

Signifier Medical TechnologiesLead Sponsor
3 Previous Clinical Trials
279 Total Patients Enrolled
1 Trials studying Snoring
115 Patients Enrolled for Snoring
Jessie P Bakker, PhDStudy DirectorSignifier Medical Technologies
2 Previous Clinical Trials
164 Total Patients Enrolled
Yasser ZayniStudy DirectorSignifier Medical Technologies
2 Previous Clinical Trials
164 Total Patients Enrolled

Media Library

eXciteOSA (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04392765 — N/A
Snoring Research Study Groups: Therapy arm
Snoring Clinical Trial 2023: eXciteOSA Highlights & Side Effects. Trial Name: NCT04392765 — N/A
eXciteOSA (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04392765 — N/A
~37 spots leftby Oct 2025